# Aňa Lluch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ana-lluch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,963 |
| Field | Breast Cancer Treatment Studies |
| h-index | 73 |
| i10-index | 250 |
| Last Known Institution | Universitat de València |
| OpenAlex ID | https://openalex.org/A5026179323 |
| ORCID iD | https://orcid.org/0000-0003-2766-407X |
| Works | 790 |

## Researcher papers

- [Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort](https://scholariq.org/papers/neoadjuvant-chemotherapy-with-trastuzumab-followed-by-adjuvant-trastuzumab/)
- [Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics](https://scholariq.org/papers/characterization-of-a-naturally-occurring-breast-cancer-subset-enriched-in/)
- [Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer](https://scholariq.org/papers/phase-iii-trial-evaluating-the-addition-of-paclitaxel-to-doxorubicin-followed-by/)
- [Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study](https://scholariq.org/papers/spanish-mediterranean-diet-and-other-dietary-patterns-and-breast-cancer-risk/)
- [Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy](https://scholariq.org/papers/feasibility-and-tolerability-of-sequential-doxorubicin-paclitaxel-followed-by/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [Universitat de València](https://scholariq.org/institutions/universitat-de-valencia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.